BioSig Technologies Reinvests in Lafayette College’s InternShift Progam
November 20, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 20, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Announces New Research Program with Mayo Clinic
November 13, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Ring NASDAQ Opening Bell on November 13, 2018
November 12, 2018 14:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal...
BioSig Technologies to Present at the 4th Annual Dawson James Small Cap Growth Conference
October 29, 2018 15:03 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal...
BioSig Technologies Begins Trading on Nasdaq
September 21, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Sept. 21, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM) a medical device company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies to Commence Trading on the Nasdaq
September 19, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM, OTCQB:BSGMD), a medical device company developing a proprietary biomedical signal processing platform...
BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System
March 28, 2018 02:00 ET
|
BioSig Technologies, Inc.
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA)...
BioSig Technologies Enters into Strategic Development Work with Health Research International
July 11, 2017 08:00 ET
|
BioSig Technologies, Inc.
Minneapolis, MN, July 11, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...